Abstract
Participants 2496 men and 1026 women (mean age 49.4 SD 6.0 years at baseline) with measurements on inflammatory markers and [ = ] anthropometry at both baseline and follow-up.
Main Outcome Measures
Change in serum CRP and IL-6 during follow-up. 
Results

The mean increases in CRP and
Conclusions
Those who were overweight or obese at baseline had a greater absolute increase in CRP per unit increase in weight, BMI and waist circumference, than people who were normal weight.
INTRODUCTION
J Clin Endocrinol Metab . Author manuscript Page / 2 7 Low-grade systemic inflammation is associated with atherosclerosis and other chronic conditions such as diabetes ( , ). C-reactive 1 2 protein (CRP, a plasma protein synthesized by the liver) and interleukin-6 (IL-6, a cytokine that governs inflammatory cascades and modulates CRP) are key biochemical markers of inflammation ( , ). It is well established that overweight and obese persons have, on 3 4 average, higher concentrations of CRP and other inflammatory markers than their leaner counterparts. ( , ). It has also been shown that 5 6 intentional weight loss leads to reduced inflammatory marker levels in the short term ( , ). However, the long-term associations of 7 8 change in weight or central obesity with changes in inflammatory markers in larger populations are poorly understood ( , ). 9 10
Accordingly, we assessed how changes in weight, BMI, and waist circumference over a period of 11 years were associated with changes in CRP and IL-6 in a large cohort of middle-aged British adults ( ). We also examined whether weight-related changes in inflammatory 11 markers differed between normal weight, overweight and obese individuals.
MATERIALS AND METHODS
Study population
Whitehall measured halfway between the costal margin and the iliac crest; measurements were recorded to the nearest 0.1 cm.
Inflammatory markers
Fasting serum was collected between 0800 and 1300 hours and was stored at 70 C. Samples from phases three and seven were −å nalysed at the same time. CRP was measured using a high-sensitivity immunonephelometric assay in a BN ProSpec nephelometer (Dade Behring, Milton Keynes, UK). IL-6 was measured using a high-sensitivity enzyme-linked immunosorbent assay (R&D Systems, Oxford, UK). Values lower than the detection limit (0.154 mg/L for CRP and 0.08 pg/mL for IL-6) were assigned a value equal to half the detection limit.
Covariates
Covariates included in the present study, measured at baseline were: age, ethnicity (White, South Asian, Black, other), socioeconomic position based on civil service employment grade (low, intermediate, high), smoking (never smoker, ex-smoker, current smoker), and leisure-time physical activity (none or mild physical activity vs. moderate activity at least 3 times or vigorous activity at least 1 2 times per -week). Coronary heart disease (CHD) was defined by using the Multinational Monitoring of trends and determinants in cardiovascular disease (MONICA) criteria ( ). Diabetes was defined by a fasting glucose of 7 0 mmol/L or more; a 2-h postload glucose of 11 1 12 · · mmol/L or more; self-report of doctor diagnosis; or use of diabetes medication ( ). 13
Statistical analysis
The distributions of CRP and IL-6 at baseline and follow-up were skewed, so the geometric means and standard deviations of logged values are presented for these variables. The distributions for the 6( ) changes in CRP and IL-6 between phases three and se ven were 13 not skewed, so the arithmetic means and standard deviations are presented for these variables.
Multivariable linear regression models were used to evaluate the relationships of change in weight, BMI and waist circumference (exposure variables) with changes in CRP and IL-6 (outcome variables). Throughout these analyses we simultaneously took into account the effect of a range of potential confounding factors. To examine whether the association was dependent on baseline obesity status, we stratified analyses by the following baseline categories of BMI: underweight/normal weight (BMI<25.0); overweight (25.0 BMI<30.0);
and obese (BMI 30.0) ( ). Statistical interaction was evaluated by including product terms between baseline BMI category and the ≥ 14 exposure variable of interest in the respective models (i.e., weight change, BMI change or change in waist during the follow-up). These analyses were performed separately for the two outcome measures.
All analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA, 2002 2003).
-
RESULTS
In the analytical sample, mean age at baseline (phase three) was 49.4 (SD 6.0) years; men constituted 71 of the sample; and most = % study participants were white ( ). Mean weight increased in this sample by 3.0 (SD 5.8) kg over 11 years of follow-up. The Table 1 = increase in BMI and waist circumference was 1.4 (SD 2.0) kg/m and 7.7 (SD 7.4) cm for all participants. On average, CRP increased by Table 2 stronger among women than men (P <0.0001 and P 0.0004,), while no sex differences were noted in the associations between change in weight, BMI or waist circumference, and IL-6.
In analyses stratified by baseline BMI categories, the relationship between change in the anthropometric measures and change in CRP was stronger in those overweight and obese at baseline, as compared with those who were lean or normal weight at baseline ( ). Table 2 This observation was unchanged irrespective of whether we used change in weight (P 0.002), BMI between change in waist circumference and baseline BMI category was statistically significant (P 0.002).
=
To test the robustness of our findings, we repeated the main multivariable linear regression analyses of weight change and change in inflammatory markers after excluding participants who had any CHD up to and including phase three (n 266), type 2 diabetes at phase = three (n 78), as well as those who reported taking lipid-lowering drugs any time during follow-up (n 420)(note that lipid lowering = = medication may affect levels of inflammation). In these analyses our conclusions were essentially unchanged (results not shown but available upon request).
DISCUSSION
We found that CRP and IL-6 levels increased over an 11-year follow-up period in a middle-aged population. The size of this increase in inflammatory markers was associated with the change in weight, BMI or waist circumference. These associations were more pronounced among those who were overweight or obese at baseline relative to normal weight persons.
The strengths of this study are use of multiple indicators of both adiposity and inflammation, and a large sample size. With little difference between the characteristics of participants at baseline and those included in this analytical sample, there was no strong evidence of selection bias (supplementary table S1 ). However, our study uses observational data, which can never provide complete inferences about causality.
In a UK community-based cohort study of 1222 participants followed over 9 years, an average increase in CRP of 0.09 mg/L per kg increase in weight was observed, which is consistent with our findings ( ). Our findings also accord with a French study of 1099 9 middle-aged participants which found significant correlations between change in BMI, waist-hip ratio and waist girth, and change in CRP, haptoglobin, orosomucoid, and between change in waist-hip ratio and waist girth and change in white blood cells, over a period of 5 years ( ). 10
To our knowledge, this is the first study to report that those who are obese may have a greater absolute increase in CRP per unit increase in subsequent weight, BMI and waist circumference, than those who are normal weight. This observed effect is plausible. Obese persons are known to have enlarged adipocytes ( , ), and adipose tissue in obese persons shows higher expression of several 8 15 pro-inflammatory proteins as compared with adipose tissue in leaner persons ( , ). It has been shown that both high BMI and 15 16 increased adipocyte size predict a proportionally higher macrophage infiltration and accumulation in adipose tissue, increasing cytokine production in obese adipose tissue ( , ). Mouse models have demonstrated that diet-induced obesity leads to a shift in the adipose 
